ACE2 Polymorphisms and COVID-19 Severity: A Study on Their Relationship with Clinical Findings
Key Points
To examine the relationship between ACE2 polymorphisms and the severity of COVID-19.
Analysis of ACE2 rs140473595 polymorphism
Assessment of COVID-19 clinical findings
Comparison across different populations
Association between ACE2 rs140473595 and increased COVID-19 severity observed
Need for further studies to clarify ACE2 variants' roles in disease progression
Abstract
The ACE2 rs140473595 polymorphism is associated with COVID-19 severity. Broader studies in diverse populations are needed to further clarify the role of ACE2 variants in disease progression.